Table 2.
Univariate and multivariate analysis of various prognostic parameters for OS in NPC
| Variables | Univariate analysis | Mutivariate analysis | ||
|---|---|---|---|---|
|
| ||||
| HR (95% CI) | P | HR (95% CI) | P | |
| Gender (F/M) | 1.055 (0.515, 2.163) | 0.884 | 0.650 (0.283, 1.495) | 0.311 |
| Age (>48 y/≤48 y) | 3.890 (1.905, 7.944) | 0.001 | 7.474 (3.189, 17.514) | 0.001 |
| T stage (T3+T4/T1+T2) | 0.915 (0.479, 1.749) | 0.789 | 1.561 (0.612, 3.985) | 0.352 |
| N stage (N1+N2+N3/N0) | 1.070 (0.506, 2.263) | 0.858 | 0.825 (0.357, 1.906) | 0.653 |
| TNM stage (III+IV/I+II) | 1.211 (0.575, 2.550) | 0.614 | 1.155 (0.380, 3.504) | 0.780 |
| Recurrence (Yes/No) | 1.561 (0.830, 2.937) | 0.167 | 0.777 (0.371, 1.630) | 0.505 |
| Metastasis (Yes/No) | 6.036 (3.225, 11.295) | 0.001 | 11.638 (4.995, 27.117) | 0.001 |
| ZDHHC2 (H.E./L.E.) | 0.441 (0.231, 0.845) | 0.014 | 0.213 (0.095, 0.480) | 0.001 |
ps: L.E.: Low Expression; H.E.: High Expression.